• Sun. Aug 14th, 2022

shoosh infosite

s….s INFO

OME Care


Dec 15, 2021

OME Care (formerly Pathway Genomics) is a privately held global precision medical diagnostic and home-care company with mobile applications. Based in San Diego, California, the company offers both at-home genetic testing and Artificial Intelligence to consumers and physicians to support treatment a variety of health conditions. The test menu ranges from pharmacogenomics testing for well-known drugs like Plavix, codeine, lamotrigine, to general health and wellness testing which includes information on a number of health conditions including obesity management, skincare, ans type 1 and type 2 diabetes and hypertension. The company has also applied for an FDA EUA[clarification needed] fast-track on a multiplex Covid-19 and influenza RT-PCR[clarification needed] diagnostic test.

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)

This article relies too much on references to primary sources. (November 2018)
This article contains content that is written like an advertisement. (November 2018)
OMEcare (OME Wellness) Corporation
Type Private
Industry Biotechnology
Founded 2009 (2009)
Founder Michael Nova
San Diego, California


United States
Website www.omecare.com

OME care owns and operates a clinical laboratory, accredited by the College of American Pathologists and Clinical Laboratory Improvement Amendments.[1]

. . . OME Care . . .

The company was founded with the vision to make “home-care genetic testing and personalized medicine accessible and affordable to everyone.”[2] OmeCare testing services cover a variety of conditions including obesity, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response.[3]

In addition to continual testing improvements and new testing developments, OME Care is also currently developing OME. OME is the “world’s only mobile healthcare consumer application with artificial intelligence to help provide consumers with personalized health and wellness information.[4]

As of January 2019, Pathway Genomics was acquired by OME Wellness and re-named OME Care.

In 2014, IBM Watson Group announced its partnership with Pathway Genomics, to help “deliver the first-ever cognitive consumer-facing app based on genetics from a user’s personal makeup.”[5] The mobile app, subsequently named OME, is the first of its kind to merge artificial intelligence and deep learning, powered by IBM Watson, with personal genetic information. It provides users with personalized health and wellness information based on the individual’s health history.[6]

OmeCare’ executives include Michael Nova, M.D. (chief innovation officer and founder) and Michael H. Cox, CIPP[clarification needed] (Privacy SoCal Privacy Consultants). [7]

. . . OME Care . . .

This article is issued from web site Wikipedia. The original article may be a bit shortened or modified. Some links may have been modified. The text is licensed under “Creative Commons – Attribution – Sharealike” [1] and some of the text can also be licensed under the terms of the “GNU Free Documentation License” [2]. Additional terms may apply for the media files. By using this site, you agree to our Legal pages . Web links: [1] [2]

. . . OME Care . . .